Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

This study has been completed.
Information provided by (Responsible Party):
Ohio State University Comprehensive Cancer Center Identifier:
First received: September 12, 2005
Last updated: April 13, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)